Author:
Palenque E,Otero J R,Noriega A R
Abstract
The in vitro susceptibilities of 83 clinical isolates of Brucella melitensis to seven cephalosporins and a monobactam were determined. Ceftizoxime, ceftriaxone, and cefotaxime were the most effective agents tested, with MICs ranging from 0.25 to 2 micrograms/ml. Moxalactam, cefoperazone, cefuroxime, and ceftazidime showed MICs between 4 and 64 micrograms/ml, with moxalactam being the most active agent in this group. Aztreonam showed poor activity, with MICs higher than 64 micrograms/ml.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference12 articles.
1. Alton G. G. L. M. Jones and D. E. Pietz. 1975. Laboratory techniques in brucellosis. World Health Organization monograph series 2nd ed. vol. 55 World Health Organization Geneva.
2. Comparison of ceftriaxone and traditional therapy of bacterial meningitis;Congeni B. L.;Antimicrob. Agents Chemother.,1984
3. Corbel M. J. 1976. Determination of in vitro sensitivity of NOTES 183
4. Protean manifestations of nervous system brucellosis;Fincham R. W.;J. Am. Med. Assoc.,1963
5. In vitro activity of N-formimidoyl thienamycin against 98 clinical isolates of Brucella melitensis compared with those of cefoxitin, rifampin, tetracycline, and co-trimoxazole;Gutierrez Altes A.;Antimicrob. Agents Chemother.,1982
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献